Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab

被引：1
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med, Dept Ophthalmol, Cluj Napoca, Romania
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词：
VEGF TRAP;
D O I：
10.3928/23258160-20170329-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [1] Reply to Letter to the Editor: Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Moshfeghi, Darius M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (04): : 281 - 281
  • [2] Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
    Wood, Edward H.
    Karth, Peter A.
    Moshfeghi, Darius M.
    Leng, Theodore
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (09): : 950 - 954
  • [3] Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab
    Ores, Raphaelle
    Philippakis, Elise
    Massin, Pascale G.
    Tadayoni, Ramin
    Dupas, Benedicte Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Short-Term Outcomes of Switching to Ranibizumab Therapy for Diabetic Macular Edema in Patients with Persistent Fluid After Bevacizumab Therapy
    Lee, Jae Hyung
    Lee, Won Ki
    Kim, Sung Eun
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (10) : 659 - 664
  • [5] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [7] Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab
    Ashraf, Mohammed
    Souka, Ahmed A. R.
    ElKayal, Hassan
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (03): : 230 - 236
  • [8] Letter to the Editor: Aflibercept For Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab And/Or Bevacizumab May Further Improve Macular Thickness
    Calugaru, Dan
    Calugaru, Mihai
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (07): : 528 - 529
  • [9] Efficacy of Ranibizumab Therapy with Aflibercept in Patients with Diabetic Macular Edema
    Teixeira, Leonardo Pinheiro
    Dalia, Eduardo
    Campos, Luana
    Abrahao, Mayara Martins
    Nassaralla, Joao J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [10] Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
    Yoshiro Minami
    Taiji Nagaoka
    Akihiro Ishibazawa
    Akitoshi Yoshida
    BMC Ophthalmology, 17
12345